| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665 |
| filingDate |
1995-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e58e03a23a02af8e5ef2199aeae4189b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_972bcd37f148b5e0be2eff002d6d8971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15a6d11847984bcd3a005b08456ae92e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f34feff2099781da42a9e33bf8a62c00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ed53f2a999ebb26c43fd2fa82a678d |
| publicationDate |
1996-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2152693-A1 |
| titleOfInvention |
Therapeutic composition for pancreatitis |
| abstract |
This invention provides a therapeutic composition for pancreatitis which comprises a phosphoric diester compound of the following formula or a pharmacologically acceptable salt thereof wherein R1 and R2 are the same or different and each represents hydrogen or methyl. The pharmaceutical composition of this invention can be used with advantage in the prevention and treatment of pancreatitis. |
| priorityDate |
1994-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |